SPECGX LLC has announced the FDA approval of its Generic ANDA075983, gaining the rights to distribute this unbranded pharmaceutical substance. This cl...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Amneal Pharmaceuticals NY LLC announced the approval of its ANDA for tramadol hydrochloride oral tablet from the FDA, initiating commercialization of ...
Teva Pharmaceuticals USA, Inc. received FDA approval for generic Tramadol Hydrochloride tablets, a development likely to intensify generic competition...
SUN PHAR INDS INC announced its approval of ANDA075964 on June 19, 2002, but the absence of both brand and generic names alongside the route of admini...
# FDA Approves Roerig's VFEND (voriconazole) for Invasive Fungal Infections Roerig has received FDA approval for VFEND (voriconazole), an oral antifu...
On May 24, 2002, Pfizer announced the approval of the oral formulation of AZITHROMYCIN DIHYDRATE for ZITHROMAX, bolstering the company's ready-to-use ...
On April 23, 2002, Apotex announced approval for its abbreviated new drug application (ANDA075984), signaling its entry into the pharma market. This r...
PHARMOBEDIENT received FDA approval for its ANDA on April 22, 2002, position the company to capture market share and increase competition within the r...
Hikma Pharmaceuticals USA Inc. secured FDA approval for its generic nasal butorphanol tartrate product, reinforcing its strategic expansion within the...
Lannett Company, Inc. leverages the regulatory milestone for its oral levothyroxine sodium formulation to secure a consistent market footprint in the ...
On February 21, 2002, Sun Pharm Industries announced the approval of generic drug application ANDA076038, subjecting the prescription to generic compe...
REGCON HOLDINGS announced the FDA approval of ANDA075807, a generic bid that expands its competitive footprint following a 2002 issuance. This regulat...
Watson Pharmaceuticals (now Actavis) received final approval from the U.S. FDA for Abbreviated New Drug Application (ANDA) 075961 on January 25, 2002....
PuraCap Laboratories LLC dba Blu Pharmaceuticals announced Wednesday the approval of its ANDA for Metformin Hydrochloride, a generic oral drug. This d...
Mylan Pharmaceuticals Inc. announced the approval of its Abbreviated New Drug Application for metformin hydrochloride, further strengthening the compa...
On January 25, 2002, Heritage Pharma received FDA approval for NDA 075978, marking the agency's authorization of a new drug. Market implications stem ...
Watson Labs has secured FDA approval for its ANDA 075979, granting launch rights for an unspecified generic formulation made essential market inroads ...
The FDA has granted approval for Lifsa Drugs, LLC’s Abbreviated New Drug Application for Metformin Hydrochloride, potentially expanding generic supply...
# FDA Approves VABRINTY (Leuprolide Acetate) for Subcutaneous Administration Uronova Pharmaceuticals, Inc. received FDA approval for VABRINTY (leupro...
Meridian Medical Technologies received updated FDA approval for the market launch of the atropine and pralidoxime chloride auto-injector, a critical a...